What is hydrochlorothiazide-irbesartan?

Category: Prescription Drugs

Most popular types: Avalide Karvezide CoAprovel

false

See also: Hydrochlorothiazide HCTZ hydrochlorothiazide-irbesartan Irbesartan

This is a combination drug that contains irbesartan, an angiotensin II receptor blocker (ARB) and hydrochlorothiazide, a diuretic. It is used for the treatment of high blood pressure.

Reported purpose & perceived effectiveness
Purpose Patients Evaluations Perceived Effectiveness
Elevated blood pressure 15 7
High blood pressure (hypertension) 4 0
Hair loss 1 1
Lupus nephritis 1 0

  • Major
  • Moderate
  • Slight
  • None
  • Can't tell

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe
0
Moderate
0
Mild
1
None
7

Commonly reported side effects and conditions associated with hydrochlorothiazide-irbesartan

Side effect Patients
Dizziness 1
Heavy sensation in head 1
Lightheadedness 1

Why patients stopped taking hydrochlorothiazide-irbesartan

Multiple reasons could be selected

Reason Patients
Doctor's advice 3
Personal research 2
Course of treatment ended 1
Did not seem to work 1
Expense 1
Other 1
Side effects too severe 1
See all 7 patients who've stopped taking hydrochlorothiazide-irbesartan

Duration

Stopped taking hydrochlorothiazide-irbesartan

Duration Patients
Less than 1 month 1
1 - 6 months 1
1 - 2 years 1
2 - 5 years 2
5 - 10 years 1
10 years or more 1
Adherence
Adherence Evaluations
Always 8
Usually 0
Sometimes 0
Never taken as prescribed 0
Burden
Burden Evaluations
Very hard to take 0
Somewhat hard to take 0
A little hard to take 0
Not at all hard to take 8
Cost per month
Cost per month Evaluations
$200+ 0
$100-199 0
$50-99 1
$25-49 3
< $25 3
Not specified 1

What people switch to and from

Patients started taking hydrochlorothiazide-irbesartan after stopping:

Treatment Patients
Amlodipine (Norvasc) 1

Patients stopped taking hydrochlorothiazide-irbesartan and switched to:

Treatment Patients
Perindopril (Coversyl) 1
Last updated:
There are no evaluations for hydrochlorothiazide-irbesartan.